Compound Detail
CHEMBL2205002
GANODERIC ACID D Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(CC(=O)C[C@@H](C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O
Basic Information
| ChEMBL ID | CHEMBL2205002 |
| Name | GANODERIC ACID D |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YTVGSCZIHGRVAV-IYAQLQCNSA-N |
7
Targets
7
Activities
2
Assay Types
0
PK Parameters
11
Publications
0
Known Names
Molecular Properties
514.7
MW (Da)
4.34
ALogP
6
HBA
2
HBD
125.8
PSA (Ų)
0.54
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 5.14
Kd 1 meas. best 7.73
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tumor necrosis factor CHEMBL1825 | Kd | 7.73 | 7.73 | 18.6 | 1 |
| P388 CHEMBL389 | IC50 | 5.14 | 5.14 | 7250.0 | 1 |
| Bel-7402 CHEMBL614279 | IC50 | 5.14 | 5.14 | 7250.0 | 1 |
| SGC-7901 CHEMBL614909 | IC50 | 5.14 | 5.14 | 7250.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.96 | 4.96 | 10860.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 4.64 | 4.64 | 22900.0 | 1 |
| HeLa CHEMBL399 | IC50 | 4.51 | 4.51 | 31000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tumor necrosis factor | Kd | = | 18.6 | nM | 7.73 | Binding affinity to TNF-alpha (unknown origin) | 24974349 |
| SGC-7901 | IC50 | = | 7250.0 | nM | 5.14 | Cytotoxicity against human SGC7901 cells | 23092389 |
| Bel-7402 | IC50 | = | 7250.0 | nM | 5.14 | Cytotoxicity against human Bel7402 cells | 23092389 |
| P388 | IC50 | = | 7250.0 | nM | 5.14 | Cytotoxicity against mouse P388 cells | 23092389 |
| NON-PROTEIN TARGET | IC50 | = | 10860.0 | nM | 4.96 | Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induc... | 27335254 |
| HepG2 | IC50 | = | 22900.0 | nM | 4.64 | Anticancer activity against human HepG2 cells assessed as cell viability after 4... | 24974349 |
| HeLa | IC50 | = | 31000.0 | nM | 4.51 | Cytotoxicity against human HeLa cells | 23092389 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 23092389 | 10.1021/np300412h | HeLa | 2 |
| 22047696 | 10.1016/j.bmcl.2011.10.035 | Aldo-keto reductase family 1 member B1 | 1 |
| 23092389 | 10.1021/np300412h | SGC-7901 | 1 |
| 23092389 | 10.1021/np300412h | Bel-7402 | 1 |
| 23092389 | 10.1021/np300412h | P388 | 1 |
| 24070782 | 10.1016/j.bmcl.2013.08.084 | Unchecked | 1 |
| 24974349 | 10.1016/j.ejmech.2014.06.037 | No relevant target | 1 |
| 24974349 | 10.1016/j.ejmech.2014.06.037 | Tumor necrosis factor | 1 |
| 24974349 | 10.1016/j.ejmech.2014.06.037 | HepG2 | 1 |
| 27335254 | 10.1016/j.bmcl.2016.06.023 | NON-PROTEIN TARGET | 1 |
| 27335254 | 10.1016/j.bmcl.2016.06.023 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine